The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Salbutamol Easyhaler Drug Master File in Japan (Salbutamol Easyhaler JDMF) empowers Salbutamol Easyhaler API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Salbutamol Easyhaler JDMF during the approval evaluation for pharmaceutical products. At the time of Salbutamol Easyhaler JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Salbutamol Easyhaler suppliers with JDMF on PharmaCompass.